Clinical and economic benefits associated with the achievement of both HbA1c and LDL cholesterol goals in veterans with type 2 diabetes. - Wikidata - awgldk - TriplyDB

Clinical and economic benefits associated with the achievement of both HbA1c and LDL cholesterol goals in veterans with type 2 diabetes.

Clinical and economic benefits associated with the achievement of both HbA1c and LDL cholesterol goals in veterans with type 2 diabetes.

http://www.wikidata.org/entity/Q37193496

about

Current Status of Management in Type 2 Diabetes Mellitus at General Hospitals in South Korea Is the choice of the statistical model relevant in the cost estimation of patients with chronic diseases? An empirical approach by the Piedmont Diabetes Registry Cardiovascular effects of dapagliflozin in patients with type 2 diabetes and different risk categories: a meta-analysis.Expanded colesevelam administration options with oral suspension formulation for patients with diabetes and hypercholesterolemia.Synergistic association of combined glycemic and blood pressure level with risk of complications in US veterans with diabetes.A National Assessment of Medication Adherence to Statins by the Racial Composition of Neighborhoods.Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial.

P2860

Q35976468-E9EA18FF-5CC7-47C7-9621-CD9FB41146B1 Q36416831-C5ED5C2D-8CF3-490A-B275-7D15433F455F Q36599869-D88EEC25-9FA5-43A7-914E-1B1551C44E24 Q38219487-9EEA73BC-D336-486D-94E8-215272D59157 Q39958676-2D1920A8-8CF2-4385-9B60-D720D9D13D6A Q40168078-5D728382-504D-4E28-BCE3-9D05999F5013 Q40619323-DEC7E9E8-EF96-48C7-B2D3-12D8DF1633D0

P2860

Clinical and economic benefits associated with the achievement of both HbA1c and LDL cholesterol goals in veterans with type 2 diabetes.

http://www.wikidata.org/entity/Q37193496

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 25 June 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Clinical and economic benefits ...... veterans with type 2 diabetes.

@en

Clinical and economic benefits ...... veterans with type 2 diabetes.

@nl

type

label

Clinical and economic benefits ...... veterans with type 2 diabetes.

@en

Clinical and economic benefits ...... veterans with type 2 diabetes.

@nl

prefLabel

Clinical and economic benefits ...... veterans with type 2 diabetes.

@en

Clinical and economic benefits ...... veterans with type 2 diabetes.

@nl

P1433

Q37193496-C4AA1277-1927-4233-A527-B3830154A28E

P1476

Q37193496-2755D07D-56E5-41BE-B7F9-E61E7EBF0D47

P2093

Q37193496-55BDC71C-5C4F-4BC7-B658-1A6E9DE47374

Q37193496-8D61E40C-DB94-4D70-B5B7-E0422A485278

Q37193496-9DCF8E82-3F0D-4957-AADC-AE428A1DCA00

Q37193496-9F5DEE4C-E088-4F9F-A978-66DDD436D871

Q37193496-E8A0E13E-727A-472A-9E87-806893E5AFA8

Q37193496-EF8807CA-5272-4961-8C1B-011E896AC334

P2860

Q37193496-034DD55D-1C93-4B3A-9C36-827CA2D3A987

Q37193496-0889C3CD-8636-4236-9412-FD3E745DF0C0

Q37193496-0B45A039-1B70-47D9-B1B5-25E9F8FE8298

Q37193496-131AFBAE-BC2A-43AA-95EF-07930E94D436

Q37193496-1892CB3A-4A3F-460E-9C50-0FB80F1EE96F

Q37193496-2C829127-671E-48C7-9D13-3FA9F9565A41

Q37193496-2DFF6520-BD1F-4755-9EA7-4C5F225AA7DB

Q37193496-3629F80A-276A-4DB6-A7D2-F19312C2F06A

Q37193496-3FB194EC-BE31-4BA1-8B4A-9F4CFD1A3773

Q37193496-4331FAAD-35FE-401A-8AF5-DF16B45FCA5B

P304

Q37193496-C4C89D5B-B694-4EA4-8830-0CF72E481E72

P31

Q37193496-3BD439C8-E71A-4A73-9ADF-4F0FB807D7F9

P356

Q37193496-DD086CF8-14C9-439E-9357-A770F378429D

P407

Q37193496-A24F8994-7370-48A8-A1F9-DBD30863D78B

P433

Q37193496-2E52D93A-B9B4-41DF-BC97-A3E7E5474927

P478

Q37193496-EC7D5986-BAF8-44CC-A4C5-07138BDD3C0F

P50

Q37193496-CE11D7AD-705C-4F3C-8173-945A3E2E470F

P577

Q37193496-E897784F-F319-4D11-8247-33836C482FD0

P5875

Q37193496-29D8BCFC-A876-4D5F-95D2-F10EE1AA3ADA

P698

Q37193496-F7C6EB5D-8CE4-4858-8C2A-A4138BCADD7F

P921

Q37193496-9156FA68-886D-4AFF-843E-8065C3A91E13

Q37193496-B69D5C0E-89CB-455E-8B09-7CAF0C0FFD40

P932

Q37193496-F0E6D102-A7AA-44BE-8E47-F1FCCEACF4EE

P356

P1433

P1476

Clinical and economic benefits ...... veterans with type 2 diabetes.

@en

P2093

Darren Thomason

http://www.w3.org/2001/XMLSchema#string

Hari Sharma

http://www.w3.org/2001/XMLSchema#string

Lizheng Shi

http://www.w3.org/2001/XMLSchema#string

Mei Lu

http://www.w3.org/2001/XMLSchema#string

Vivian A Fonseca

http://www.w3.org/2001/XMLSchema#string

Xin Ye

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials

Standards of medical care in diabetes--2012

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

Glucose control and vascular complications in veterans with type 2 diabetes

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

Effects of medical therapies on retinopathy progression in type 2 diabetes

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial.

Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.

A mathematical model for the determination of total area under glucose tolerance and other metabolic curves.

P304

3297-3304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC13-0149

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-06-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

242017666

http://www.w3.org/2001/XMLSchema#string

P698

23801723

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

3781519

http://www.w3.org/2001/XMLSchema#string